SCHEMBL14899243

SCHEMBL14899243

CCN1CCN(C(=O)c2ccccc2C)CC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.71
MAPT P10636 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
CCR6 P51684 1/20 0.56
ALDH1A1 P00352 3/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
HTR2B P41595 1/20 0.56
MAPK14 Q16539 1/20 0.56
USP2 O75604 1/20 0.55
TSHR P16473 1/20 0.55
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
HSD17B10 Q99714 1/20 0.55
HSD11B1 P28845 2/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
CYP3A4 P08684 1/20 0.54
HPGD P15428 1/20 0.54
LMNA P02545 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10722320 0.88 HTT (0.89) HTTMAPTNPSR1CCR6ALDH1A1
SCHEMBL12333385 0.84 HRH4 (0.55) HTTALDH1A1USP2TSHRHSD11B1
SCHEMBL14825166 0.83 HTT (1.00) HTTMAPTNPSR1ALDH1A1CYP2C9
SCHEMBL4548030 0.81 HTT (0.77) HTTMAPTNPSR1CCR6ALDH1A1
SCHEMBL3088384 0.81 HTT (0.77) HTTMAPTNPSR1CCR6ALDH1A1
SCHEMBL11960839 0.81 SMN1; SMN2 (0.52) HTTMAPTALDH1A1USP2TSHR
SCHEMBL30530619 0.81 HTT (0.89) HTTMAPTNPSR1ALDH1A1CYP2C9
SCHEMBL13162411 0.81 HTT (0.96) HTTMAPTNPSR1ALDH1A1CYP2C9
SCHEMBL1520613 0.81 HTT (0.89) HTTMAPTNPSR1ALDH1A1CYP2C9
SCHEMBL12305558 0.80 HSD11B1 (0.49) HTTMAPTALDH1A1HSD11B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431713-B2 2-aminopyridine derivatives as glucokinase activators ARRAY BIOPHARMA, INC. (US) 2013-04-30 US disclosed